Safety and efficacy of NOAC vs. VKA in patients treated by PCI: a retrospective study of the FRANCE PCI registry
IntroductionDual antithrombotic therapy (DAT) combining oral anticoagulation (OAC), preferentially Non-vitamin K antagonist OAC (NOAC) and single antiplatelet therapy (SAPT) for a period of 6–12 months is recommended after percutaneous coronary intervention (PCI) in patients with an indication for O...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2024-01-01
|
| Serier: | Frontiers in Cardiovascular Medicine |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1320001/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
